- Home
- DVA vs HSIC Comparison
DVA vs HSIC Comparison
Compare DVA & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- HSIC
- Stock Information
- Founded
- DVA 1994
- HSIC 1932
- Country
- DVA United States
- HSIC United States
- Employees
- DVA N/A
- HSIC N/A
- Industry
- DVA Misc Health and Biotechnology Services
- HSIC Medical Specialities
- Sector
- DVA Health Care
- HSIC Health Care
- Exchange
- DVA Nasdaq
- HSIC Nasdaq
- Market Cap
- DVA 10.5B
- HSIC 9.0B
- IPO Year
- DVA 1995
- HSIC 1995
- Fundamental
- Price
- DVA $135.44
- HSIC $67.84
- Analyst Decision
- DVA Hold
- HSIC Buy
- Analyst Count
- DVA 2
- HSIC 11
- Target Price
- DVA $162.00
- HSIC $75.64
- AVG Volume (30 Days)
- DVA 925.7K
- HSIC 2.1M
- Earning Date
- DVA 08-05-2025
- HSIC 08-05-2025
- Dividend Yield
- DVA N/A
- HSIC N/A
- EPS Growth
- DVA 8.72
- HSIC 15.03
- EPS
- DVA 10.20
- HSIC 3.11
- Revenue
- DVA $13,161,328,000.00
- HSIC $12,773,000,000.00
- Revenue This Year
- DVA $6.51
- HSIC $4.31
- Revenue Next Year
- DVA $3.41
- HSIC $3.57
- P/E Ratio
- DVA $13.28
- HSIC $21.82
- Revenue Growth
- DVA 5.09
- HSIC 2.29
- 52 Week Low
- DVA $126.07
- HSIC $60.56
- 52 Week High
- DVA $179.60
- HSIC $82.49
- Technical
- Relative Strength Index (RSI)
- DVA 46.24
- HSIC 45.80
- Support Level
- DVA $128.28
- HSIC $64.90
- Resistance Level
- DVA $135.58
- HSIC $69.10
- Average True Range (ATR)
- DVA 3.76
- HSIC 1.83
- MACD
- DVA -0.39
- HSIC 0.09
- Stochastic Oscillator
- DVA 44.11
- HSIC 61.03
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.